TY  - JOUR
AU  - Chamorro, Virginia
AU  - Morales Cano, Daniel
AU  - Milara, Javier
AU  - Barreira, Bianca
AU  - Moreno Gutiérrez, Laura
AU  - Callejo, Maria
AU  - Mondejar Parreño, Gema
AU  - Esquivel Ruiz, Sergio Antonio
AU  - Cortijo, Julio
AU  - Cogolludo Torralba, Ángel Luis
AU  - Barberá, Joan A.
AU  - Pérez Vizcaíno, Francisco
AU  - De Jesús Pérez, Vinicio A. 
PY  - 2018
DO  - 10.1371/journal.pone.0191239
SN  - 1932-6203
UR  - https://hdl.handle.net/20.500.14352/97449
T2  - PLoS ONE
AB  - IntroductionCurrent treatment with vasodilators for pulmonary hypertension associated with respiratory diseases is limited by their inhibitory effect on hypoxic pulmonary vasoconstriction (HPV) and uncoupling effects on ventilation-perfusion (V’/Q’)....
LA  - eng
PB  - Public Library of Science
KW  - Medical hypoxia
KW  - Oxygen
KW  - Vasodilators
KW  - Pulmonary fibrosis
KW  - Pulmonary arteries
KW  - Vasoconstriction
KW  - Arteries
KW  - Chronic obstructive pulmonary disease
TI  - Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching
TY  - journal article
VL  - 13
ER  -